Reaction

Metastases To Heart reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 300 reports · 5 co-occurring drugs

As of the last recalculation, Metastases To Heart appears in 300 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is GEFITINIB (PRR 47.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Gefitinib647.047.1
Dabrafenib1137.637.6
Lanreotide Acetate435.935.9
Trametinib1235.835.9
Ifosfamide929.929.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.